Xenetic Biosciences, Inc. (XBIO): Revenue
$2.98M
Year ended 2025-12-31
$3.26M
Trailing 12 months to 2026-06-30
+20.4%
3-year compound annual growth
+46.8%
5-year compound annual growth
| Period ended | Revenue | Change YoY | Source filing |
|---|---|---|---|
| 2025-12-31 | $2.98M | +19.0% | 2026-03-12, From 2025-01-01 |
| 2024-12-31 | $2.50M | -1.6% | 2026-03-12, From 2024-01-01 |
| 2023-12-31 | $2.54M | +48.8% | 2025-03-18, From 2023-01-01 |
| 2022-12-31 | $1.71M | +47.1% | 2024-03-21, From 2022-01-01 |
| 2021-12-31 | $1.16M | +165.6% | 2023-03-22, From 2021-01-01 |
| 2020-12-31 | $436.9K | n/m | 2022-03-22, From 2020-01-01 |
| 2019-12-31 | $17.1K | n/a | 2021-03-16, From 2019-01-01 |
| 2018-12-31 | $0 | -100.0% | 2020-03-26, From 2018-01-01 |
| 2017-12-31 | $7.58M | +152.8% | 2019-03-29, From 2017-01-01 |
| 2016-12-31 | $3.00M | n/a | 2018-03-30, From 2016-01-01 |
| 2015-12-31 | $0 | n/a | 2017-03-31, From 2015-01-01 |
| 2014-12-31 | $0 | -100.0% | 2015-04-15, From 2014-01-01 |
| 2013-12-31 | $1.00M | +240.6% | 2015-07-20, From 2013-01-01 |
| 2012-12-31 | $293.6K | n/a | 2015-07-20, From 2012-01-01 |
Revenue at similar companies
| Company | Year ended | Revenue | Change YoY |
|---|---|---|---|
| Xenetic Biosciences, Inc. (XBIO) | 2025-12-31 | $2.98M | +19.0% |
| TherapeuticsMD, Inc. (TXMD) | 2025-12-31 | $3.02M | +71.6% |
| Upstream Bio, Inc. (UPB) | 2025-12-31 | $2.85M | +20.4% |
| Cartesian Therapeutics, Inc. (RNAC) | 2025-12-31 | $2.80M | -92.8% |
| Camp4 Therapeutics Corp (CAMP) | 2025-12-31 | $3.50M | +436.5% |
| Marker Therapeutics, Inc. (MRKR) | 2025-12-31 | $3.55M | -46.2% |
| GeoVax Labs, Inc. (GOVX) | 2025-12-31 | $2.49M | -37.1% |
| CervoMed Inc. (CRVO) | 2025-12-31 | $4.01M | -58.9% |
| China Pharma Holdings, Inc. (CPHI) | 2025-12-31 | $4.14M | -8.5% |
Compare XBIO, TXMD, UPB, RNAC side by side · Screen every company in Pharmaceutical Preparations ↗